Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy

Beyond glycemic control in type 2 diabetes, semaglutide blunts appetite, which is why it drives weight loss
Given the spiralling costs of obesity-related health complications, Aziz believes that it could make a significant difference in the coming years
A: Lyophilized (dry powder) peptides are more stable store them in the fridge or freezer before reconstitution
Stay well-hydrated before and after treatments, maintain a balanced diet, keep up with regular physical activity, and follow all our post-treatment guidance